A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.
For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...
Understanding Bioinformatics Workflows for NGS Analysis: Case Study with Whole-exome Sequencing Data
NGS enables the in-depth analysis of the genome and the identification and investigation of disease-associated variants–especially when workflows include target enrichment, which focuses on specific ...
INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) ...
Employing Liquid-Handling Automation For Faster and More Reliable Results In the next three years, the number of next-generation sequencing (NGS) samples processed will more than double. The NGS ...
The Tecan Group and Oxford Nanopore Technologies plc (Oxford Nanopore) today announce their collaboration to drive easier high-throughput nanopore library preparation in an automated, hands-free ...
Company will showcase ultrasensitive platform for high-throughput screening applications at SLAS2023 alongside its newest NGS liquid handler while highlighting other workflow innovations The EnVision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback